Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
183 | 3 | NOONAN SYNDROME//PTEN//CELL BIOLOGY | 56293 |
1406 | 2 | JNK//ERK5//COFFIN LOWRY SYNDROME | 8266 |
23101 | 1 | TAK1//5Z 7 OXOZEAENOL//TAB1 | 380 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | TAK1 | authKW | 2786623 | 22% | 40% | 84 |
2 | 5Z 7 OXOZEAENOL | authKW | 716818 | 3% | 79% | 11 |
3 | TAB1 | authKW | 580553 | 4% | 50% | 14 |
4 | TGF BETA ACTIVATED KINASE 1 | authKW | 559828 | 2% | 75% | 9 |
5 | TAB3 | authKW | 451549 | 2% | 78% | 7 |
6 | TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 | authKW | 294882 | 2% | 44% | 8 |
7 | LYTAK1 | authKW | 248815 | 1% | 100% | 3 |
8 | TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 TAK1 | authKW | 186609 | 1% | 75% | 3 |
9 | 7 AMINO FURO2 3 CPYRIDINE | authKW | 165876 | 1% | 100% | 2 |
10 | LYSINE 158 | authKW | 165876 | 1% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Cell Biology | 1486 | 33% | 0% | 124 |
2 | Biochemistry & Molecular Biology | 1145 | 46% | 0% | 175 |
3 | Oncology | 439 | 19% | 0% | 73 |
4 | Immunology | 140 | 11% | 0% | 41 |
5 | Medicine, Research & Experimental | 57 | 6% | 0% | 22 |
6 | Biophysics | 51 | 5% | 0% | 20 |
7 | Chemistry, Medicinal | 37 | 4% | 0% | 14 |
8 | Genetics & Heredity | 28 | 5% | 0% | 19 |
9 | Rheumatology | 27 | 2% | 0% | 7 |
10 | Hematology | 22 | 3% | 0% | 12 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PATHOGEN BIOCHEM | 130142 | 5% | 8% | 19 |
2 | BIOPHYS BIOCHEM S625A | 82938 | 0% | 100% | 1 |
3 | CARDIOMETAB NUTRINSERMICANUMR S1166 | 82938 | 0% | 100% | 1 |
4 | CELL ENGN BIOL ENGN | 82938 | 0% | 100% | 1 |
5 | CELL SIGNALLINGBUNKYO KU | 82938 | 0% | 100% | 1 |
6 | DIC PATHOGEN BIOCHEM | 82938 | 0% | 100% | 1 |
7 | HEPATOBILICNY PANCREAT SURG | 82938 | 0% | 100% | 1 |
8 | HOST DEF EXPLORATORY ADV TECHNOL ERATO | 82938 | 0% | 100% | 1 |
9 | ICRM CHEM MOL RECOGNIT | 82938 | 0% | 100% | 1 |
10 | MED GENETINSERMUMR 1163 HP IMAGINE | 82938 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CELLULAR SIGNALLING | 1168 | 2% | 0% | 8 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1106 | 12% | 0% | 46 |
3 | TUMOR BIOLOGY | 580 | 2% | 0% | 7 |
4 | FEBS OPEN BIO | 556 | 1% | 0% | 2 |
5 | CELL DEATH & DISEASE | 493 | 1% | 0% | 4 |
6 | SCIENCE SIGNALING | 460 | 1% | 0% | 3 |
7 | SEIKAGAKU | 425 | 1% | 0% | 3 |
8 | CELL DEATH AND DIFFERENTIATION | 394 | 1% | 0% | 4 |
9 | CELL CHEMICAL BIOLOGY | 375 | 0% | 0% | 1 |
10 | MOLECULAR CANCER RESEARCH | 375 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
rank | cluster_id2 | link |
---|---|---|
1 | 14076 | IRAK 4//TIR DOMAIN//IRAK |
2 | 37112 | NEMO LIKE KINASE//NLK//UNIT NERVOUS DEV SYST |
3 | 22122 | RESORCYLIC ACID LACTONES//LASIODIPLODIN//HYPOTHEMYCIN |
4 | 9442 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
5 | 15559 | BCL10//PKC THETA//CARMA3 |
6 | 3336 | DEUBIQUITINATING ENZYME//DEUBIQUITINASE//UBIQUITIN |
7 | 29481 | TPL2//TPL 2//MAP3K8 |
8 | 529 | NF KAPPA B//IKK//I KAPPA B |
9 | 23414 | ASK1//PP5//PROTEIN PHOSPHATASE 5 |
10 | 6295 | MK2//P38 INHIBITORS//P38 ALPHA |